What Happened?
New Haven, CT-based Arvinas Promoted Andy Crew as Chief Technology Officer
New Haven, CT-based Arvinas Promoted Andy Crew as Chief Technology Officer
Arvinas is a pharmaceutical company focused on developing new small molecules ‒ known as PROTACs (PROteolysis TArgeting Chimeras) ‒ aimed at degrading disease-causing cellular proteins via proteolysis. Based on innovative research conducted at Yale University by Dr. Craig Crews, Founder and Chief Scientific Advisor, the company is translating natural protein degradation approaches into novel drugs for the treatment of cancer and other diseases. The proprietary PROTAC-based drug paradigm induces protein degradation, rather than protein inhibition, using the ubiquitin proteasome system and offers the advantage of potentially targeting “undruggable” as well as “druggable” elements of the proteome. This greatly expands the ability to create drugs for many new, previously unapproachable targets.
Andy Crew is Chief Technology Officer at Arvinas. Previously, Andy held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Mangano Joey, Scarpulla Dan, Amidon Robert, Potter Bruce, Tyrka Keith, Vlahinos Andreas, Wimer Luke, Kupper Randy, Sokka Sham, Bennett Lyndee, Vargas Abraham
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.